Working Memory Training in Young ADHD Children

Working Memory Training: A Randomised Controlled Treatment Study in Young ADHD Children

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00819611

Enrollment

Registered

2009-01-09

Start date

2009-06-30

Completion date

2013-12-31

Last updated

2014-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Disorder With Hyperactivity

Keywords

Attention deficit disorder with hyperactivity, Working memory training, Placebo, Behavioral symptoms, Neuropsychology, Electropsychophysiology

Brief summary

The purpose of this study is to investigate whether working memory training improves behavioral symptoms, neurocognitive performance, and neural functioning in young children with ADHD.

Interventions

BEHAVIORALCogmed Working memory training

15 minutes of working memory training, 5 days a week for a period of 5 weeks

BEHAVIORALControl version of Cogmed working memory training

15 minutes of 'sham' working memory training, 5 days a week for a period of 5 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

54 Months to 88 Months

Healthy volunteers

Inclusion criteria

* Age between 4 years/6 months and 7 years/4 months * Diagnosis ADHD, classified by the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 2000) * A full scale IQ \>= 80 * Psychopharmaca- naïve or -free * Access to a PC with Windows Vista or Windows XP with internet connection and speakers at home

Exclusion criteria

* Currently intensive (i.e. weekly) individual or group psychotherapy * Regular use of medication * Diagnosis of one or more of the following comorbid psychiatric disorders: Major depression, Bipolar disorder, Psychotic disorder, Chronically motor tic disorder or Gilles de la Tourette, Conduct disorder, any other autism spectrum disorder except for Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS), Eating disorders, Anxiety disorders * Neurological disorders (e.g. epilepsy) currently or in the past * Cardiovascular disease currently or in the past * Serious motor or perceptual handicap * Participation in another clinical trial simultaneously * Educational level and/ or socio-economic situation that makes it unlikely for the family to fulfil this study

Design outcomes

Primary

Measure	Time frame
ADHD criteria according to the DSM-IV-TR rated by the investigator	7 weeks

Secondary

Measure	Time frame
Neurocognitive performance and electrocortical activity	7 weeks

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026